Thomas Brady is listed as an executive officer on 1 SEC Form D filing by 1 issuer in Feb 2018: Flow Pharma, Inc. (Warrensville Heights, OH — biotechnology — 2018; $2.26M reported sold to 42 investors).
What this means One deal on file with the SEC, filed Feb 2018. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Lester John Lloyd (1 shared filing) and Reid Martin Rubsamen (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Thomas. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 court case matching the name, 6 bankruptcy cases matching the name listed in Key records below.
What this means 7 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Thomas Brady and found 7 differences, 1 worth asking the sponsor about: Form D filed 709 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.